All Publications

  • Changes in foot progression angle during gait reduce the knee adduction moment and do not increase hip moments in individuals with knee osteoarthritis. Journal of biomechanics Seagers, K., Uhlrich, S. D., Kolesar, J. A., Berkson, M., Kaneda, J. M., Beaupre, G. S., Delp, S. L. 2022; 141: 111204


    People with knee osteoarthritis who adopt a modified foot progression angle (FPA) during gait often benefit from a reduction in the knee adduction moment. It is unknown, however, whether changes in the FPA increase hip moments, a surrogate measure of hip loading, which will increase the mechanical demand on the joint. This study examined how altering the FPA affects hip moments. Individuals with knee osteoarthritis walked on an instrumented treadmill with their baseline gait, 10° toe-in gait, and 10° toe-out gait. A musculoskeletal modeling package was used to compute joint moments from the experimental data. Fifty participants were selected from a larger study who reduced their peak knee adduction moment with a modified FPA. In this group, participants reduced the first peak of the knee adduction moment by 7.6% with 10° toe-in gait and reduced the second peak by 11.0% with 10° toe-out gait. Modifying the FPA reduced the early-stance hip abduction moment, at the time of peak hip contact force, by 4.3% ± 1.3% for 10° toe-in gait (p = 0.005, d = 0.49) and by 4.6% ± 1.1% for 10° toe-out gait (p < 0.001, d = 0.59) without increasing the flexion and internal rotation moments (p > 0.15). Additionally, 74% of individuals reduced their total hip moment at time of peak hip contact force with a modified FPA. In summary, when adopting a FPA modification that reduced the knee adduction moment, participants, on average, did not increase surrogate measures of hip loading.

    View details for DOI 10.1016/j.jbiomech.2022.111204

    View details for PubMedID 35772243

  • Assessing inertial measurement unit locations for freezing of gait detection and patient preference. Journal of neuroengineering and rehabilitation O'Day, J., Lee, M., Seagers, K., Hoffman, S., Jih-Schiff, A., Kidzinski, L., Delp, S., Bronte-Stewart, H. 2022; 19 (1): 20


    BACKGROUND: Freezing of gait, a common symptom of Parkinson's disease, presents as sporadic episodes in which an individual's feet suddenly feel stuck to the ground. Inertial measurement units (IMUs) promise to enable at-home monitoring and personalization of therapy, but there is a lack of consensus on the number and location of IMUs for detecting freezing of gait. The purpose of this study was to assess IMU sets in the context of both freezing of gait detection performance and patient preference.METHODS: Sixteen people with Parkinson's disease were surveyed about sensor preferences. Raw IMU data from seven people with Parkinson's disease, wearing up to eleven sensors, were used to train convolutional neural networks to detect freezing of gait. Models trained with data from different sensor sets were assessed for technical performance; a best technical set and minimal IMU set were identified. Clinical utility was assessed by comparing model- and human-rater-determined percent time freezing and number of freezing events.RESULTS: The best technical set consisted of three IMUs (lumbar and both ankles, AUROC=0.83), all of which were rated highly wearable. The minimal IMU set consisted of a single ankle IMU (AUROC=0.80). Correlations between these models and human raters were good to excellent for percent time freezing (ICC=0.93, 0.89) and number of freezing events (ICC=0.95, 0.86) for the best technical set and minimal IMU set, respectively.CONCLUSIONS: Several IMU sets consisting of three IMUs or fewer were highly rated for both technical performance and wearability, and more IMUs did not necessarily perform better in FOG detection. We openly share our data and software to further the development and adoption of a general, open-source model that uses raw signals and a standard sensor set for at-home monitoring of freezing of gait.

    View details for DOI 10.1186/s12984-022-00992-x

    View details for PubMedID 35152881